Nirogacestat Hydrobromide is the hydrobromide salt form of nirogacestat, a selective gamma secretase (GS) inhibitor with antitumor activity. Upon administration, nirogacestat targets and binds to GS, thereby blocking the proteolytic activation of Notch receptors. This inhibits the Notch signaling pathway and results in the induction of apoptosis in tumor cells that overexpress Notch. The integral membrane protein GS is a multi-subunit protease complex that cleaves single-pass transmembrane proteins, including Notch receptors, at residues within their transmembrane domains. Overexpression of the Notch signaling pathway has been correlated with increased tumor cell growth and survival. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Ogsiveo and nirogacestat HBr. Its PubChem CID is 121513889.
Nirogacestat hydrobromide
| CAS No | 1962925-29-6 |
|---|---|
| Molecular Formula | C27H43Br2F2N5O |
| Molecular Weight | 651.5 g/mol |
| Synonyms | (2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide;dihydrobromide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nirogacestat Hydrobromide is the hydrobromide salt form of nirogacestat, a selective gamma secretase (GS) inhibitor with antitumor activity. Upon administration, nirogacestat targets and binds to GS, thereby blocking the proteolytic activation of Notch receptors.
The listed CAS number is 1962925-29-6.
The listed molecular formula is C27H43Br2F2N5O.
The listed molecular weight is 651.5 g/mol.
(2S)-2-[[(2S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl]amino]-N-[1-[1-(2,2-dimethylpropylamino)-2-methylpropan-2-yl]imidazol-4-yl]pentanamide;dihydrobromide.
The source lists Ogsiveo and nirogacestat HBr.